Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Cipla beats Q1 profit view on robust demand Ruchika Sharma27 July 2024 3:07 PM ISTHyderabad: Drugmaker, Cipla, has exceeded profit expectations for the first quarter of the fiscal year, driven by a significant increase in sales...
Dr Reddy's Labs expects strong product pipeline in North America for FY25 Ruchika Sharma9 May 2024 5:47 PM ISTBengaluru: Dr. Reddy's Laboratories, based in India, forecasts a strong product lineup for its key market in North America in the fiscal year...
Sun Pharma reports bigger-than-expected rise in Q2 profit Ruchika Sharma1 Nov 2023 12:30 PM ISTThe company's generic version of popular cancer drug Revlimid is also a significant contributor to the total sales.
Cipla reports bigger-than-expected rise in Q2 profit Ruchika Sharma28 Oct 2023 6:15 AM ISTHigher market share in cancer drugs Revlimid and Lanreotide and lower price erosion have helped Cipla's sales in the North American market, analysts...
Cancer drug: Dr Reddy's arm faces antitrust complaint in US over Revlimid Ruchika Sharma11 Oct 2023 3:30 PM ISTTelangana: Dr Reddy’s Laboratories, Inc., a wholly-owned step-down subsidiary of Dr Reddy’s Laboratories Limited, along with several other...
Bristol Myers plans to double experimental treatments to expand research pipeline Ruchika Sharma17 Sept 2023 3:00 PM ISTNew York: Bristol Myers Squibb has said it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies,...
Giovanni Caforio to retire as Bristol Myers Squibb CEO Ruchika Sharma30 April 2023 1:30 PM ISTNew York: Bristol Myers Squibb has announced that Giovanni Caforio, MD, Chairman of the Board and Chief Executive Officer, has decided to retire...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 2:15 PM ISTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report Farhat Nasim22 Nov 2022 6:36 PM ISTNew Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...
